EXHIBIT 1
JOINT FILING AGREEMENT
The undersigned agree that the statement on Schedule 13G with respect to the securities of Syros Pharmaceuticals, Inc. is, and any amendments thereto signed by each or any of the undersigned shall be, filed on behalf of each of such person pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: August 2, 2024
INVUS PUBLIC EQUITIES, L.P. | ||
By: | INVUS PUBLIC EQUITIES ADVISORS, | |
LLC, its general partner | ||
By: | /s/ Raymond Debbane | |
Name: | Raymond Debbane | |
Title: | President | |
INVUS PUBLIC EQUITIES ADVISORS, LLC | ||
By: | /s/ Raymond Debbane | |
Name: | Raymond Debbane | |
Title: | President | |
INVUS GLOBAL MANAGEMENT, LLC | ||
By: | /s/ Raymond Debbane | |
Name: | Raymond Debbane | |
Title: | President | |
SIREN, L.L.C. | ||
By: | /s/ Raymond Debbane | |
Name: | Raymond Debbane | |
Title: | President | |
MR. RAYMOND DEBBANE | ||
By: /s/ Raymond Debbane |
ARTAL INTERNATIONAL S.C.A. | ||
By: | ARTAL INTERNATIONAL | |
MANAGEMENT S.A., its managing partner | ||
By: | /s/ Anne Goffard | |
Name: | Anne Goffard | |
Title: | Managing Director | |
ARTAL INTERNATIONAL MANAGEMENT S.A. | ||
By: | /s/ Anne Goffard | |
Name: | Anne Goffard | |
Title: | Managing Director | |
ARTAL GROUP S.A. | ||
By: | /s/ Anne Goffard | |
Name: | Anne Goffard | |
Title: | Authorized Person | |
WESTEND S.A. | ||
By: | /s/ Anne Goffard | |
Name: | Anne Goffard | |
Title: | Managing Director | |
STICHTING ADMINISTRATIEKANTOOR WESTEND | ||
By: | /s/ Amaury Wittouck | |
Name: | Amaury Wittouck | |
Title: | Sole Member of the Board | |
MR. AMAURY WITTOUCK | ||
/s/ Amaury Wittouck |